The USA-India Chamber of Commerce (USAIC) has announced the agenda of its 17th annual BioPharma & Healthcare Summit, which will be held virtually on May 3, 2023. The summit aims to support the BioPharma community in these unprecedented times.

US FDA Commissioner Dr Robert Califf will attend the event. Johnson & Johnson’s chairman and CEO, Joaquin Duato, Pfizer’s chairman and CEO Albert Bourla, Biogen’s CEO Christopher Viehbacher, Merck’s former chairman & CEO Kenneth Frazier, and academic leaders from Harvard and MIT have demonstrated interest to collaborate with India, the release stated.

According to the release, USAIC is a powerful platform for shared learning on science and technology and is crucial for successful performance in the complex world of BioPharma and Healthcare.

On fostering innovation, Karun Rishi, president of USAIC, said, "I am encouraged by the response of young colleagues. They are the future leaders in the healthcare and life science industry. We must do everything to help the next generation of leaders."

"I see India on the path to becoming an innovation powerhouse in BioPharma in the coming years. India has tremendous needs and potential in the area of BioPharma and Healthcare Innovation,” Rishi noted while adding they should scale up research and development, translational research, industry-academic partnerships, clinical trial or manufacturing.

The summit will have a special session to discuss BioPharma research and development, clinical trials, and the global supply chain by bringing together G20 Sherpa Amitabh Kant and industry leaders. “Today’s healthcare challenges are complex. A united global response will be more effective than individual countries acting independently. India’s leadership at G20 this year can be a defining moment to address these critical issues for patients worldwide,” Rishi added.

Andrew Plump, president of R&D, Takeda and Chair, of USAIC BioPharma & Healthcare Summit, excited to participate in the summit, said, "This year, with India on track to become the world’s most populous country, our responsibility to ensure its people benefit from these innovations that improve human health has never been greater."

Meanwhile, Amitabh Kant, India's G20 Sherpa, urged G20 member countries, businesses, academics, and scientists to collaborate and focus on evidence-based research and analytics to ensure preparedness in health systems and build adaptable global supply chains that can deliver instantaneously during a crisis.

UK net migration fell to an estimated 204,000 in the year ending June 2025, according to provisional figures released Nov. 27 by the Office for National Statistics. The drop marks a steep decline from 649,000 a year earlier and from the 2023 peak of 944,000.

The ONS said the fall was driven by fewer non-EU nationals arriving to work or study and a continued rise in people leaving the country. Most departures in the period were non-EU nationals, many of whom had initially entered on study visas.

Home Secretary Shabana Mahmood welcomed the decline, calling net migration “at its lowest level in half a decade.” She said it had “fallen by more than two-thirds under this government,” adding that the pace of arrivals had put pressure on local communities. She separately pointed to reforms she announced earlier this month to tighten settlement rules and overhaul the asylum system.

Shadow Home Secretary Chris Philp argued the fall stemmed from Conservative measures introduced in 2024 on work, dependant and student visas. He said the drop “doesn’t go far enough,” and repeated his party’s pledge to leave the European Convention on Human Rights and remove people who enter the UK illegally.

The Home Office released its own data the same day. It reported 110,051 asylum claims in the year ending September 2025 and said 51,249 people arrived through illegal routes, most by small boat. It also said 36,273 asylum seekers were housed in hotels as of September.

Prime Minister Keir Starmer called the ONS figures “a step in the right direction.” He said he remains “determined to close all our asylum hotels,” though the latest numbers show hotel use rising compared with earlier this year.

Migration researchers warned the decline may not last. Madeleine Sumption of the Migration Observatory said the fall is partly explained by EU citizens who came before Brexit and are now leaving, a trend that “won’t go on forever.” She noted that non-EU migration remains far higher than pre-Brexit levels and that a larger share of arrivals is coming through the asylum system.